Eli Lilly signs a $409 million research deal with AI-powered drug discovery startup Genetic Leap

• Facebook
• Tweet
• Pinterest
• Reddit
• Email

Global pharmaceutical leader Eli Lilly has struck a research agreement with AI-driven drug discovery startup Genetic Leap. The deal is worth $409 million, according to an announcement by Genetic Leap on Thursday. As part of the deal, Genetic Leap will
The post Eli Lilly signs a $409 million research deal with AI-powered drug discovery startup Genetic Leap first appeared on Tech Startups.

Global pharmaceutical leader Eli Lilly has struck a research agreement with AI-driven drug discovery startup Genetic Leap. The deal is worth $409 million, according to an announcement by Genetic Leap on Thursday. As part of the deal, Genetic Leap will […]

The post Eli Lilly signs a $409 million research deal with AI-powered drug discovery startup Genetic Leap first appeared on Tech Startups.

Read More